306 related articles for article (PubMed ID: 19479943)
21. [Sentinel lymph node for breast cancer: remove less to know more].
Fortunato L; Benzoni C; Amini M; Alessi G; Manni C; Andrich R; Di Nardo A; Crenca F; Bianca S; Farina M; Vitelli CE
Minerva Chir; 2001 Oct; 56(5):439-49. PubMed ID: 11568718
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques.
Pelosi E; Bellò M; Giors M; Ala A; Giani R; Bussone R; Bisi G
J Nucl Med; 2004 Feb; 45(2):220-5. PubMed ID: 14960639
[TBL] [Abstract][Full Text] [Related]
23. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
24. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping.
Gray RJ; Pockaj BA
Am J Surg; 2004 Oct; 188(4):423-5. PubMed ID: 15474440
[TBL] [Abstract][Full Text] [Related]
25. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
26. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
27. [Application of sentinel lymph node biopsy by subareolar injection of blue dye in the treatment of breast carcinoma].
Xiao H; Li ZX; Chen X; Gong JZ
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):806-7. PubMed ID: 15363301
[TBL] [Abstract][Full Text] [Related]
28. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
Liu LC; Lang JE; Jenkins T; Lu Y; Ewing CA; Hwang SE; Sokol S; Alvarado M; Esserman LJ; Morita E; Treseler P; Leong SP
J Am Coll Surg; 2008 Dec; 207(6):853-8. PubMed ID: 19183531
[TBL] [Abstract][Full Text] [Related]
29. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.
King TA; Fey JV; Van Zee KJ; Heerdt AS; Gemignani ML; Port ER; Sclafani L; Sacchini V; Petrek JA; Cody HS; Borgen PI; Montgomery LL
Ann Surg Oncol; 2004 May; 11(5):535-41. PubMed ID: 15123464
[TBL] [Abstract][Full Text] [Related]
30. Added value of blue dye in sentinel node biopsy for breast cancer.
Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer.
Lo YF; Cheung YC; Hsueh S; Ho KC
Chang Gung Med J; 2009; 32(1):51-8. PubMed ID: 19292939
[TBL] [Abstract][Full Text] [Related]
32. [Sentinel lymph node detection in patients with early-stage breast cancer: which site of injection in 2011?].
Frati A; Delpech Y; Bricou A; Barranger E
Gynecol Obstet Fertil; 2011 Nov; 39(11):620-3. PubMed ID: 21873098
[TBL] [Abstract][Full Text] [Related]
33. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
35. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
36. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
37. Factors predicting failure to identify a sentinel lymph node in breast cancer.
Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
[TBL] [Abstract][Full Text] [Related]
38. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital.
Lo YF; Hsueh S; Ma SY; Chen SC; Chen MF
Chang Gung Med J; 2006; 29(5):458-67. PubMed ID: 17214389
[TBL] [Abstract][Full Text] [Related]
39. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
Kavallaris A; Camara O; Runnebaum IB
J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
[TBL] [Abstract][Full Text] [Related]
40. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.
Bauer TW; Spitz FR; Callans LS; Alavi A; Mick R; Weinstein SP; Bedrosian I; Fraker DL; Bauer TL; Czerniecki BJ
Ann Surg Oncol; 2002 Mar; 9(2):169-76. PubMed ID: 11888875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
